Literature DB >> 20178809

Can estrogens promote hypertension during systemic lupus erythematosus?

Marcia Venegas-Pont1, Michael J Ryan.   

Abstract

SLE is a chronic autoimmune inflammatory disorder that predominantly affects young women. Based on this observation, it has been speculated that sex steroids, particularly estrogens, contribute to SLE disease progression. Young women with SLE are at an increased risk for the development of hypertension yet the reasons for this are unclear. One potential mechanism for the increased risk of hypertension during SLE is the chronic inflammation caused by immune complex mediated tissue injury. Estrogens are known to have an immunomodulatory role that can lead to the production of characteristic autoantibodies important for immune complex formation. Therefore, it is conceivable that during SLE estrogens contribute to tissue injury, increased inflammation and hypertension. This brief review discusses the increased risk for hypertension during SLE, the role of estrogens in immune system function, evidence for estrogens in SLE, and a possible link between estrogens and SLE hypertension. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178809      PMCID: PMC2896984          DOI: 10.1016/j.steroids.2010.02.010

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  77 in total

1.  Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat.

Authors:  David L Mattson; Leilani James; Elizabeth A Berdan; Carla J Meister
Journal:  Hypertension       Date:  2006-06-05       Impact factor: 10.190

2.  Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.

Authors:  Chi Chiu Mok; Chi Hung To; Anselm Mak; Kwok Man Ma
Journal:  Arthritis Rheum       Date:  2005-12

3.  The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

Authors:  Jill P Buyon; Michelle A Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Joan T Merrill; Lisa Sammaritano; Michael Lockshin; Graciela S Alarcón; Susan Manzi; H Michael Belmont; Anca D Askanase; Lisa Sigler; Mary Anne Dooley; Joan Von Feldt; W Joseph McCune; Alan Friedman; Jane Wachs; Mary Cronin; Michelene Hearth-Holmes; Mark Tan; Frederick Licciardi
Journal:  Ann Intern Med       Date:  2005-06-21       Impact factor: 25.391

4.  Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.

Authors:  Michael J Ryan; Gerald R McLemore; Steven T Hendrix
Journal:  Hypertension       Date:  2006-09-18       Impact factor: 10.190

Review 5.  Estrogens in pregnancy and systemic lupus erythematosus.

Authors:  Andrea Doria; Luca Iaccarino; Piercarlo Sarzi-Puttini; Anna Ghirardello; Sandra Zampieri; Silvia Arienti; Maurizio Cutolo; Silvano Todesco
Journal:  Ann N Y Acad Sci       Date:  2006-06       Impact factor: 5.691

6.  Combined oral contraceptives in women with systemic lupus erythematosus.

Authors:  Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

Review 7.  Estrogens and autoimmune diseases.

Authors:  Maurizio Cutolo; Silvia Capellino; Alberto Sulli; Bruno Serioli; Maria Elena Secchi; Barbara Villaggio; Rainer H Straub
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 8.  Immune responses and bone loss: the estrogen connection.

Authors:  Hans Carlsten
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

Review 9.  Sex differences in autoimmune disease.

Authors:  M D Lockshin
Journal:  Lupus       Date:  2006       Impact factor: 2.911

10.  Mortality in systemic lupus erythematosus.

Authors:  S Bernatsky; J-F Boivin; L Joseph; S Manzi; E Ginzler; D D Gladman; M Urowitz; P R Fortin; M Petri; S Barr; C Gordon; S-C Bae; D Isenberg; A Zoma; C Aranow; M-A Dooley; O Nived; G Sturfelt; K Steinsson; G Alarcón; J-L Senécal; M Zummer; J Hanly; S Ensworth; J Pope; S Edworthy; A Rahman; J Sibley; H El-Gabalawy; T McCarthy; Y St Pierre; A Clarke; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  2006-08
View more
  3 in total

1.  Estrogen: good, bad, or both?

Authors:  Olga Rafikova; Jennifer C Sullivan
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

Review 2.  Hypertension: what's sex got to do with it?

Authors:  Margaret A Zimmerman; Jennifer C Sullivan
Journal:  Physiology (Bethesda)       Date:  2013-07

3.  Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies.

Authors:  Li Qin; Yiwen Zhang; Xiaoqian Yang; Han Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-11       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.